1. Home
  2. Approved trials
  3. » فارسی

Evaluation of the effect of RIPC (remote ischemic preconditioning) on migrane headache and Brain metabolites in MRS (magnetic resonance spectroscopy) and qEEG indices of migraine patients a pilot study

Protocol summary

Study aim
Evaluation of the effect of RIPC (remote ischemic preconditioning) on migrane headache and Brain metabolites in MRS (magnetic resonance spectroscopy) and qEEG indices of migraine patients a pilot study
Design
This study is a parallel double-blind clinical trial on 30 patients with intervention(RIPC group) and control group (RIPC like group). Sample allocation will be based on the limited randomization approach using block randomization.
Settings and conduct
Location: Neurology Clinic of Poursina Hospital, Rasht.The outcome assessor and data analyzer are blinded and samples are randomly selected.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients have at least 5 headache attacks lasting 4–72 hours (without treatment or unsuccessful treatment) ,Age range 18 to 50, Gender of male and female, The onset of migraines before menopause,Patient's ability to distinguish migraine headaches from other conditions,Ability to fill out a questionnaire,Patient consent to enter the study,Signed informed consent. Exclusion criteria: Types of risk factors, history of chronic diseases or kidney, liver, cardiovascular, renal, pulmonary diseases, any malignancy, autoimmunity,diabetes mellitus. Convulsions. Menopause. head and neck trauma.Existence of cognitive impairment. Botox injections in the last 6 months.Pregnancy and lactation. Severe hypertension greater than 160/90 mm / hg.Non-migraine headaches. Drug and alcohol dependence. History of off pump surgery.
Intervention groups
Group A (intervention group: patients undergoing procedure); Group B (control group: patients undergoing RIPC-like procedure as described in method).
Main outcome variables
Glutamate, choline, creatine, N-acetyl aspartate, myoinositol GABA Glutamate/Cr NAA/Cr myoinisitol/Cr Frequency bands, Coherence

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210212050334N4
Registration date: 2022-06-17, 1401/03/27
Registration timing: prospective

Last update: 2022-06-17, 1401/03/27
Update count: 0
Registration date
2022-06-17, 1401/03/27
Registrant information
Name
Amaneh Mohammadi Roushandeh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 13 3333 1520
Email address
mohammadi_roushandeh@gums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-08-06, 1401/05/15
Expected recruitment end date
2023-03-20, 1401/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of the effect of RIPC (remote ischemic preconditioning) on migrane headache and Brain metabolites in MRS (magnetic resonance spectroscopy) and qEEG indices of migraine patients a pilot study
Public title
Evaluation of the effect of RIPC (remote ischemic preconditioning) on migrane headache and Brain metabolites in MRS (magnetic resonance spectroscopy) and qEEG indices of migraine patients a pilot study
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Patient have at least 5 headache attacks lasting 4–72 hours (without treatment or unsuccessful treatment) Age range from 18 to 50 years The onset of migraines before menopause The ability of patients to distinguish migraine headaches from other conditions The patient's ability to fill out questionnaire Both male and female gender Informed consent
Exclusion criteria:
Underlying diseases, history of chronic diseases or kidney, liver, cardiovascular, renal, pulmonary diseases, any malignancy, autoimmunity, diabetes mellitus Convulsions Menopause Head and neck trauma Asthenic damage Mental disorders and major depression according to DSM4 Botox injection in the last 6 months Pregnancy and lactation Non-migraine headaches such as tension headaches that occur more than 12 times a month and cervicogenic Drug and alcohol dependence during the 1 year prior to the study Migraine with aura History of off pump surgery Severe hypertension higher than 160/90 mm / hg Rheumatism
Age
From 18 years old to 50 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 30
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, restricted randomization method in the form of block randomization will be used to allocate patients into intervention and control groups. The "R" software will be used for randomization. For this purpose, four blocks with a ratio of 1: 1 will be considered. Sequences are marked in sealed envelopes with the letters A (intervention group) and B (control group). We will consider the size of the blocks randomly with a size of 4 to prevent the latest allocation from being detected. In the randomization process, random allocation sequences are identified by a statistician, and one student collaborators in the project will register participants and allocate them to interventions.
Blinding (investigator's opinion)
Double blinded
Blinding description
In the present study, according to the type of intervention approach used, patients, nurses and physicians will be aware of the new treatment process and there is no way to not inform them and they are not blind. However,data analyzer and who assesses the patients outcomes are blind . Therefore, the present study is designed for double blinds.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethic Committees of Guilan University of Medical science
Street address
Vice Chancellor of Research and Technology of Guilan University of Medical Sciences,Shahid Siadati St., Namjoo St.
City
Rasht
Province
Guilan
Postal code
4193713194
Approval date
2022-03-09, 1400/12/18
Ethics committee reference number
IR.GUMS.REC.1400.603

Health conditions studied

1

Description of health condition studied
Migraine
ICD-10 code
G43.711
ICD-10 code description
Chronic migraine without aura, intractable, with status migrainosus

Primary outcomes

1

Description
Glutamate
Timepoint
Days 0 and 60
Method of measurement
Magnetic resonance spectroscopy (MRS) test

2

Description
N-acetyl aspartate
Timepoint
Days 0 and 60
Method of measurement
MRS test

3

Description
Choline
Timepoint
Days 0 and 60
Method of measurement
MRS test

4

Description
Creatine
Timepoint
Days 0 and 60
Method of measurement
MRS test

5

Description
Myoinositol
Timepoint
Days 0 and 60
Method of measurement
MRS test

6

Description
GABA
Timepoint
Days 0 and 60
Method of measurement
MRS test

7

Description
Glutamate/Creatine
Timepoint
Days 0 and 60
Method of measurement
Math

8

Description
NAA/Cr
Timepoint
Days 0and 60
Method of measurement
Math

9

Description
Choline/Cr
Timepoint
Days 0 and 60
Method of measurement
Math

10

Description
Myoinisitol/Cr
Timepoint
Days 0and 60
Method of measurement
Math

11

Description
Absolute frequency bands
Timepoint
Days 0 and 60
Method of measurement
Qeeg

12

Description
Relative frequency bands
Timepoint
days 0and 60
Method of measurement
Qeeg

13

Description
Coherence
Timepoint
Days 0 and 60
Method of measurement
Qeeg analyze

Secondary outcomes

1

Description
Migraine-induced disability
Timepoint
Days 0 and 90
Method of measurement
According to the MIDAS index

Intervention groups

1

Description
Intervention group: Intervention group: The patient undergoes RIPC protocol 6 days a week. sphygmomanometer will be attached to the patient's arm and will be remained under the pressure of 200 mmHg for 5 minutes (ischemic phase) , followed by 5 minutes of rest (reperfusion phase). This cycle will be performed 3 times.
Category
Treatment - Other

2

Description
Control group: In the control group, this operation is performed as a sham or pseudo-ischemia, no pressure is applied.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Poursina hospital
Full name of responsible person
Amaneh Mohammadi Roushandeh
Street address
Poursina hospital,Parastar street, Rasht, Guilan
City
Rasht
Province
Guilan
Postal code
4144666949
Phone
+98 13 3333 5820
Fax
+98 13 3333 6395
Email
mohammadi_roushandeh@gums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Dr. Mohammadreza Naghipour
Street address
Deputy of Research and Technology, Namjoo Street, Siadati street, Rasht, Guilan
City
Rasht
Province
Guilan
Postal code
4144666949
Phone
+98 13 3333 5820
Fax
+98 13 3333 6395
Email
research@gums.ac.ir
Web page address
https://www.gums.ac.ir/research
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Rasht University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Amaneh Mohammadi Roushandeh
Position
استادتمام
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
Anatomical Sciences department, Medicine faculty, Guilan University of Medical Sciences, Rasht, Guilan
City
Rasht
Province
Guilan
Postal code
4144666949
Phone
+98 13 3333 5820
Fax
+98 13 3336 8540
Email
mohammadi_roushandeh@gums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Amaneh Mohammadi Roushandeh
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
Anatomical Sciences department, Medicine faculty, Guilan University of Medical Sciences, Rasht, Guilan
City
Rasht
Province
Tehran
Postal code
4144666949
Phone
+98 13 3333 5820
Fax
+98 13 3336 8540
Email
mohammadi_roushandeh@gums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Amaneh Mohammadi Roushandeh
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Anatomy
Street address
Anatomical Sciences department, Medicine faculty, Guilan University of Medical Sciences, Rasht, Guilan
City
Rasht
Province
Guilan
Postal code
4144666949
Phone
+98 13 3333 5820
Fax
+98 13 3336 8540
Email
mohammadi_roushandeh@gums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...